1 study found for:    18354418 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
Conditions: Mestatic Melanoma;   Skin Cancer
Interventions: Drug: Fludarabine;   Drug: Cycolphosphamide;   Drug: Aldesleukin;   Drug: MART-1 Reactive CD8+ PBL

Indicates status has not been verified in more than two years